コンテンツへスキップ
Merck
  • Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25.

Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25.

Experimental and therapeutic medicine (2017-09-21)
Dan Liu, Ting Liu, Yue Teng, Wei Chen, Le Zhao, Xu Li
要旨

Metastasis frequently occurs in advanced ovarian cancer, which not only leads to substantial mortality but also becomes a major challenge to effective treatment. Epithelial-mesenchymal transition (EMT) is a key mechanism facilitating cancer metastasis. Targeting the EMT process with more efficacious and less toxic agents to prevent metastasis is of significant therapeutic value for ovarian cancer treatment. The anti-EMT function and mechanism of ginsenoside Rb1, a monomer composition extracted from the traditional Chinese herb

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクローナル抗EP300抗体 マウス宿主抗体, clone 1B1, purified immunoglobulin, buffered aqueous solution
カタログ番号
容量
在庫状況
単価
数量